ADRES Intl Biotech Consultation & Execution

We have over 30 years of experience with the FDA and leading regulatory bodies around the globe. Providing regulatory affairs, QA, CMC in the States, Europe, Brazil, India China and Israel - from R&D and early-stage startups to big pharma, we are highly experienced in a variety of pharmaceutical fields including vaccines, biologicals, cell therapies and ATMPs, botanical drugs, liposomes and medical devices, all in pursuit of treatment for an array of medical conditions. ADRES EU (Netherlands based) provides international startups access to the EMA interface, providing regulatory, financial and administrative assistance. Our European SME status allows us to conduct...

Regulatory affairs,quality assurance,consulting,cmc/engineering,biopharma,biomedicine,fda,ema,moh,gene therapy,combination products,novel drugs,orphan drugs,clinical studies,pre-clinical studies,ind/impd/nda/bla,and medical device

Adres intl biotech consultation & execution operates in the Biotechnology research industry.

Adres intl biotech consultation & execution's revenue is 11m - 100m

Adres intl biotech consultation & execution has 11 - 50 employees.